ASX Penny Stock Highlights: Ai-Media Technologies And Two Other Noteworthy Picks
Name
Share Price
Market Cap
Financial Health Rating
Alfabs Australia (ASX:AAL)
A$0.375
A$107.47M
★★★★☆☆
EZZ Life Science Holdings (ASX:EZZ)
A$2.46
A$116.05M
★★★★★★
GTN (ASX:GTN)
A$0.63
A$120.15M
★★★★★★
IVE Group (ASX:IGL)
A$2.85
A$439.42M
★★★★★☆
Southern Cross Electrical Engineering (ASX:SXE)
A$1.785
A$471.97M
★★★★★★
Tasmea (ASX:TEA)
A$3.66
A$862.38M
★★★★★☆
Navigator Global Investments (ASX:NGI)
A$1.695
A$830.68M
★★★★★☆
Lindsay Australia (ASX:LAU)
A$0.74
A$234.75M
★★★★☆☆
Bisalloy Steel Group (ASX:BIS)
A$3.54
A$167.97M
★★★★★★
CTI Logistics (ASX:CLX)
A$1.755
A$141.36M
★★★★☆☆
Click here to see the full list of 477 stocks from our ASX Penny Stocks screener.
Let's dive into some prime choices out of the screener.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Ai-Media Technologies Limited offers technology-driven captioning, transcription, and translation services across Australia, New Zealand, Singapore, Malaysia, North America, and the United Kingdom with a market cap of A$116.94 million.
Operations: The company's revenue is derived from its Internet Software & Services segment, amounting to A$65.30 million.
Market Cap: A$116.94M
Ai-Media Technologies Limited, with a market cap of A$116.94 million and revenue of A$65.30 million, is leveraging its LEXI platform to expand accessibility in multilingual broadcasting. Recent partnerships with Lightning International and AudioShake enhance its real-time translation capabilities, opening new revenue streams by breaking language barriers across global markets. While currently unprofitable, Ai-Media has improved its financial position over the past five years and maintains a sufficient cash runway for more than three years due to positive free cash flow growth. Despite these strengths, the company faces challenges such as an inexperienced board and ongoing unprofitability.
Take a closer look at Ai-Media Technologies' potential here in our financial health report.
Review our growth performance report to gain insights into Ai-Media Technologies' future.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Helloworld Travel Limited is a travel distribution company operating in Australia, New Zealand, and internationally with a market cap of A$243.36 million.
Operations: The company's revenue is primarily generated from its Travel Operations in Australia (A$153.71 million), New Zealand (A$36.06 million), and the Rest of the World (A$3.72 million), along with contributions from its Transport, Logistics and Warehousing segment (A$15.20 million).
Market Cap: A$243.36M
Helloworld Travel Limited, with a market cap of A$243.36 million, is strategically positioned in the travel industry but faces challenges such as declining net profit margins and negative earnings growth over the past year. Despite this, it remains debt-free and offers a dividend yield of 7.38%, though not fully covered by free cash flows. Recent M&A activity suggests potential consolidation with Webjet Group, which could enhance its online booking capabilities if pursued successfully. The company trades at a favorable price-to-earnings ratio of 9.3x compared to the broader Australian market and has shown stable weekly volatility over the past year.
Dive into the specifics of Helloworld Travel here with our thorough balance sheet health report.
Gain insights into Helloworld Travel's outlook and expected performance with our report on the company's earnings estimates.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: SciDev Limited offers environmental solutions for water-intensive industries across Australia, the United States, Asia, and other international markets, with a market cap of A$68.43 million.
Operations: The company's revenue is primarily derived from its Chemical Services segment, which generated A$85.79 million, followed by the Water Technology segment with A$23.04 million.
Market Cap: A$68.43M
SciDev Limited, with a market cap of A$68.43 million, is trading at 51% below its estimated fair value, indicating potential undervaluation in the penny stock segment. The company has transitioned to profitability over the past year and forecasts suggest earnings growth of 45.4% annually. SciDev's financial health appears robust with short-term assets covering both short and long-term liabilities, while its interest payments are well covered by EBIT at 7.2x coverage. However, despite having more cash than total debt and stable weekly volatility (10%), the company's Return on Equity remains low at 4%.
Navigate through the intricacies of SciDev with our comprehensive balance sheet health report here.
Assess SciDev's future earnings estimates with our detailed growth reports.
Click this link to deep-dive into the 477 companies within our ASX Penny Stocks screener.
Ready For A Different Approach? This technology could replace computers: discover the 27 stocks are working to make quantum computing a reality.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:AIM ASX:HLO and ASX:SDV.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
HPMT Holdings Berhad (KLSE:HPMT) Has Some Difficulty Using Its Capital Effectively
What financial metrics can indicate to us that a company is maturing or even in decline? More often than not, we'll see a declining return on capital employed (ROCE) and a declining amount of capital employed. Trends like this ultimately mean the business is reducing its investments and also earning less on what it has invested. And from a first read, things don't look too good at HPMT Holdings Berhad (KLSE:HPMT), so let's see why. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Return On Capital Employed (ROCE): What Is It? For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. The formula for this calculation on HPMT Holdings Berhad is: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.033 = RM5.3m ÷ (RM171m - RM12m) (Based on the trailing twelve months to March 2025). Therefore, HPMT Holdings Berhad has an ROCE of 3.3%. In absolute terms, that's a low return and it also under-performs the Machinery industry average of 8.0%. See our latest analysis for HPMT Holdings Berhad Historical performance is a great place to start when researching a stock so above you can see the gauge for HPMT Holdings Berhad's ROCE against it's prior returns. If you're interested in investigating HPMT Holdings Berhad's past further, check out this free graph covering HPMT Holdings Berhad's past earnings, revenue and cash flow. So How Is HPMT Holdings Berhad's ROCE Trending? There is reason to be cautious about HPMT Holdings Berhad, given the returns are trending downwards. About five years ago, returns on capital were 5.5%, however they're now substantially lower than that as we saw above. And on the capital employed front, the business is utilizing roughly the same amount of capital as it was back then. This combination can be indicative of a mature business that still has areas to deploy capital, but the returns received aren't as high due potentially to new competition or smaller margins. So because these trends aren't typically conducive to creating a multi-bagger, we wouldn't hold our breath on HPMT Holdings Berhad becoming one if things continue as they have. The Key Takeaway In the end, the trend of lower returns on the same amount of capital isn't typically an indication that we're looking at a growth stock. It should come as no surprise then that the stock has fallen 30% over the last five years, so it looks like investors are recognizing these changes. Unless there is a shift to a more positive trajectory in these metrics, we would look elsewhere. If you want to know some of the risks facing HPMT Holdings Berhad we've found 3 warning signs (1 is potentially serious!) that you should be aware of before investing here. While HPMT Holdings Berhad may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
36 minutes ago
- Yahoo
Howmet vs. General Dynamics: Which Aerospace & Defense Stock Should You Bet On?
Howmet Aerospace Inc. HWM and General Dynamics Corporation GD are two prominent names operating in the aerospace and defense industry. As rivals, both companies are engaged in producing highly engineered aircraft components for commercial and military aircraft in the United States and companies have been enjoying significant growth opportunities in the aerospace and defense space on account of the improving air traffic trend and the expansionary U.S. budgetary policy in the past couple of years. But which one is a better investment today? Let's take a closer look at their fundamentals, growth prospects and challenges to make an informed choice. The Case for Howmet The strongest driver of Howmet's business at the moment is the commercial aerospace market. Persistent strength in air travel has been driving demand for wide-body aircraft, supporting continued OEM spending. Pickup in air travel has been positive for the company as the increased usage of aircraft spurs spending on parts and products that it provides. Revenues from the commercial aerospace market increased 9% year over year in first-quarter 2025, constituting 52% of its business. The sustained strength was attributed to new, more fuel-efficient aircraft with reduced carbon emissions and increased spare demand for the commercial aerospace market has remained a major driver for the company, the defense side of the industry has also been witnessing positive momentum, cushioned by steady government support. The company has been witnessing robust orders for engine spares for the F-35 program and spares and new builds for legacy the first quarter, revenues from the defense aerospace market increased 19% year over year, constituting 17% of the company's revenues. Improved budgetary provisions from the U.S. government set the stage for Howmet, focused on defense business, to win more contracts, which is likely to boost its top company also remains committed to increasing shareholder value through dividend payouts and share repurchases. In the first three months of the year, it paid dividends worth $42 million and repurchased shares for $125 million. In January 2025, the company hiked its quarterly dividend by 25% to 10 cents per share. Also, in July 2024, its board approved an increase in the share repurchase program by $2 billion to $2.487 billion of its common the positives, HWM has been subject to continued weakness in the commercial transportation market over the past few quarters. Demand in the commercial transportation markets served by the Forged Wheels segment is expected to remain soft till the second half of the year due to lower OEM builds. The Case for General Dynamics General Dynamics had an impressive backlog of $88.66 billion at the end of the first quarter of 2025, driven by a strong order inflow. The estimated contract value, which combines the total backlog with the potential contract value, totaled $141.33 billion at the end of the quarter. The strength of the order flow was driven by strong demand across the company's product and services from its well-established domestic market, the company enjoys significant overseas opportunities across multiple nations, particularly in Europe, for its Land Systems unit's products. In first-quarter 2025, it witnessed robust demand for its combat system products, with particular strength in U.S. fiscal budgets have played a key catalyst for the growth of General Dynamics' Marine Systems business. Notably, in May 2025, a White House report published that U.S. President Trump proposed an increase in the nation's defense spending (to $1.01 trillion) for fiscal 2026. This should bode well for GD with its strong presence in the defense shipbuilding the global supply-chain disorder plagued by disruptions, delays and shortages has impacted the company. Evidently, within its Aerospace business, supply-chain challenges forced GD to ramp up production in response to strong customer demand for its aircraft and caused out-of-sequence manufacturing. This resulted in increased costs and reduced operational efficiency for General Dynamics in Dynamics' highly leveraged balance sheet also remains concerning. Its long-term debt totaled $7.26 billion exiting first-quarter 2025, while its short-term debt was $2.35 billion. The company's cash and cash equivalents amounted to $1.24 billion, which were lower than both its short-term and long-term debt. Considering its debt profile, GD holds a weak solvency position. Price Performance In the past year, Howmet shares have soared 142%, while General Dynamics stock has gained 4.1%. Image Source: Zacks Investment Research The Zacks Consensus Estimate for HWM & GD The Zacks Consensus Estimate for HWM's 2025 sales and earnings per share (EPS) implies year-over-year growth of 8.7% and 29%, respectively. HWM's EPS estimates for both 2025 and 2026 have increased over the past 60 days. Image Source: Zacks Investment Research The Zacks Consensus Estimate for GD's 2025 sales and EPS implies year-over-year growth of 5.9% and 9.9%, respectively. GD's EPS estimates have been trending northward over the past 60 days for both 2025 and 2026. Image Source: Zacks Investment Research GD's Valuation Attractive Than Howmet General Dynamics is trading at a forward 12-month price-to-earnings ratio of 18.77X, above its median of 17.48X over the last three years. Howmet's forward earnings multiple sits at 49.21X, much higher than its median of 26.09X over the same time frame. Image Source: Zacks Investment Research Final Take General Dynamics' strength in the aerospace and defense markets has been dented by the continued supply-chain challenges arising from component shortages. The company's solid momentum in domestic and international markets adds to its strength. However, its high debt profile remains a contrast, Howmet's market leadership position and strength in both commercial and defense aerospace markets provide it with a competitive advantage to leverage the long-term demand prospects in the aerospace market. Despite its steeper valuation, HWM holds robust prospects due to strong estimates, stock price appreciation and better prospects for sales and profit these factors, HWM seems to be a better pick for investors than GD currently. While HWM currently carries a Zacks Rank #2 (Buy), GD has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report General Dynamics Corporation (GD) : Free Stock Analysis Report Howmet Aerospace Inc. (HWM) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
‘Important': Albo's China jaunt defended
A senior Labor minister has hit back at the opposition for criticising Anthony Albanese's lengthy state visit to China, saying the relationship with Australia's biggest trading partner had 'broken down' on the Coalition's watch. The Prime Minister spent much of the last week touting Australia's tourism, trade and research offerings in Shanghai, Beijing and Chengdu as part of a five-day business and diplomatic blitz. But the Opposition has argued the trip did not produce any tangible outcomes, despite several agreements being signed. Attorney-General Michelle Rowland said on Sunday she found the 'criticism quite extraordinary considering that since we came to government we have removed some $20 billion of trade impediments with China'. China imposed trade restrictions during a trade war with the Morrison-Coalition government. 'We now have in everything from wine to lobster, not to mention the fact that China is our single biggest trading partner,' Ms Rowland told Sky News. 'Our resources sector relies on that relationship.' She noted that Mr Albanese's visit was 'at the invitation … of China'. 'He went with a significant business delegation,' Ms Rowland. 'This is about creating jobs and extra trade opportunities for Australia, and it's important that we maintain this vital relationship.' The business community, represented by the Business Council of Australia (BCA), has praised the trip. The BCA was central to many of Mr Albanese's engagements in China, including high-level talks with Chinese officials and business leaders. With Mr Albanese meeting with Xi Jinping while a face-to-face with Donald Trump elusive, Ms Rowland was asked how she thought the China trip would go down in Washington. 'Our relationship with China is obviously important, as is our relationship with the United States,' she said. 'But here, there are different purposes. 'We will engage in the national interest wherever we can with China. 'We will always act in the national interest, and often we will disagree. 'But this is important from the perspective of our trade and of stabilising that relationship, which, quite frankly, had broken down under successive Liberal governments. 'And it's important that we have a government now that's acting in our national interest, in the interest of jobs and trade and certainty.' Ms Rowland, who sits on the National Security Committee, also downplayed concerns around the Trump administration's demand to hike Australian defence spending and its commitment to AUKUS – a $360bn submarine pact with the US and UK underpinning Canberra's defence strategy for the first half of the 21st century. While Mr Albanese was in China, the man leading the US review of AUKUS hinted Australia would need to guarantee support for the US if a conflict broke out in the Indo-Pacific over Taiwan. It came after the Financial Times reported Mr Colby asked Australia and Japan what they would do to defend the democratically self-governed island from China. Ms Rowland said she was 'not going to engage in hypotheticals' but that the Albanese government did 'not support a unilateral change' on Taiwan. 'What I will note, in going to a related issue about defence spending, that we recognise the US has called for this of a number of its allies,' she said. 'But again, I would point out that we are spending some $10bn over the forwards and nearly $60bn over the next decade on defence spending. 'We will act always in the national interest, and we will ensure that our capabilities are up to scratch.' She refused to comment on National Security deliberations on the US' AUKUS review, but said that 'there is nothing unusual about a new administration having a review of these relationships'. 'But again, we view AUKUS as fundamental to our relationship with the United States, and we are confident in its execution,' Ms Rowland said.
